Primary laryngeal lymphoma in China: a retrospective study of the last 25 years

2019 ◽  
Vol 133 (09) ◽  
pp. 792-795
Author(s):  
P Zhao ◽  
Y Zhou ◽  
J Li

AbstractObjectiveTo retrospectively study the primary laryngeal lymphoma cases in China reported in Chinese-language literature.MethodChinese-language literature was searched for papers on primary laryngeal lymphoma published in the last 25 years.ResultsThe selected papers comprised a total of 115 cases. The male-to-female ratio was 3.4:1. Non-Hodgkin's lymphoma was the exclusive pathological type. The estimated 3-year, 5-year and 10-year survival rates were 70.9 ± 6.4 per cent, 63.4 ± 7.6 per cent and 56.4 ± 9.5 per cent respectively, as determined by Kaplan–Meier analysis. B-cell non-Hodgkin's lymphoma patients had a better prognosis than T-cell non-Hodgkin's lymphoma patients (p = 0.032). Patients with lymph node involvement at diagnosis had a poorer prognosis (p < 0.01).ConclusionPrimary laryngeal lymphoma is a rare disease with no specific clinical features. More than one biopsy might be needed to obtain the correct diagnosis. Proper treatment could lead to promising outcomes. The T-cell subtype and lymph node involvement at diagnosis might indicate worse prognosis.

2014 ◽  
Vol 25 ◽  
pp. v90
Author(s):  
Kazuhiko Natori ◽  
Daisuke Nagase ◽  
Susumu Ishihara ◽  
Akiko Sakai ◽  
Motohiro Kato ◽  
...  

Blood ◽  
1993 ◽  
Vol 82 (8) ◽  
pp. 2510-2516 ◽  
Author(s):  
AC Lambrechts ◽  
PE Hupkes ◽  
LC Dorssers ◽  
MB van't Veer

Abstract Stage I and II follicular non-Hodgkin's lymphoma (NHL) is clinically defined as a localized disease. To study the possibility that this disease is in fact disseminated, we used the sensitive polymerase chain reaction (PCR) method using translocation (14;18) as marker. Samples from 21 patients who were clinically diagnosed with stage I or II follicular NHL were analyzed for the presence of t(14;18)-positive cells using PCR. We analyzed (1) the diagnostic lymph node biopsy and (2) the peripheral blood or bone marrow samples from these patients. Translocation (14;18) cells were detected in the diagnostic lymph node biopsies of 12 patients. In 9 of these patients, t(14;18)-positive cells were detected in peripheral blood and/or bone marrow samples at diagnosis and/or after therapy. Thus, in 75% of the follicular NHL patients carrying the t(14;18) as a marker for lymphoma cells, t(14;18)- positive cells were detected in peripheral blood and bone marrow at diagnosis and after therapy. Our results show that t(14;18)-positive cells can be detected in the circulation of patients with stage I and II follicular NHL, indicating that, although diagnosed as localized, the disease is disseminated.


1989 ◽  
Vol 80 (8) ◽  
pp. 720-726 ◽  
Author(s):  
Kazuyuki Shimizu ◽  
Nobuyuki Hamajima ◽  
Kazunori Ohnishi ◽  
Kazuo Hara ◽  
Akira Kunii

Sign in / Sign up

Export Citation Format

Share Document